Rein Therapeutics Inc.
RNTX
$1.76
-$0.15-7.85%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -62.88M | -29.24M | -25.22M | -18.07M | -15.73M |
| Total Depreciation and Amortization | 63.00K | 115.00K | 127.00K | 135.00K | 119.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 38.12M | 1.43M | 1.11M | 1.03M | 1.19M |
| Change in Net Operating Assets | 2.41M | -176.00K | -1.71M | -3.52M | -5.38M |
| Cash from Operations | -22.29M | -27.87M | -25.69M | -20.42M | -19.81M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | 0.00 | 42.00K | 42.00K | 42.00K |
| Cash Acquisitions | -- | -96.00K | -96.00K | -96.00K | -96.00K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00 | 500.00K | 9.00M | 16.25M |
| Cash from Investing | -- | -96.00K | 446.00K | 8.95M | 16.20M |
| Total Debt Issued | -- | 15.79M | 15.79M | 15.79M | 15.79M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 18.26M | 18.26M | 18.26M | -- | -- |
| Repurchase of Common Stock | -7.48M | -7.48M | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 7.03M | 7.03M | -- | -- | -- |
| Cash from Financing | 17.82M | 33.61M | 34.06M | 15.79M | 15.79M |
| Foreign Exchange rate Adjustments | 0.00 | -62.00K | -62.00K | -63.00K | -63.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.47M | 5.58M | 8.75M | 4.26M | 12.12M |